Table 2.

Clinical presentation of Kaposi’s sarcoma in HIV-patients with suppressed viremia in main published series.

Reference	Number of Subjects: Total (Male/Female)	Median Age of Subjects: Years	Skin or Palatine Involvement	Lymph Node Involvement	Visceral Involvement Oedema or Ulceration or Nodular Oral Lesions
[5]	9 (-/-)	51 (range: 41–74)	9 (100%)	0	0
[6]	20 (19/1)	42 (range: 25–59)	12 (60%)		8 (40%)
[7]	21 (17/4)	54 (interquartile: 35–61)	Skin, 21 (100%) Palatine, 1 (5%)	6 (27%)	Bronchi, 4 (18%) Bone, 4 (18%) Stomach/esophagus, 3 (14%)
[8]	12 (12/0)	54 (range: 38–60)	Skin 10 (83.3%)	1 (8.3%)	Lung, 1 (8.3%)